Stockholders’ Equity (Details Narrative) - USD ($)					1 Months Ended	2 Months Ended	3 Months Ended		12 Months Ended
	Feb. 04, 2022	Feb. 01, 2022	Sep. 09, 2018	Sep. 05, 2018	Feb. 28, 2022	Apr. 04, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2021
Subsidiary or Equity Method Investee [Line Items]
Preferred stock, shares outstanding							0			0
Proceeds from warrants exercised							$ 163,000
Warrant [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares issued for common stock							60,374
Proceeds from warrants exercised							$ 200,000
Number of warrants exercised							60,374
Series A Preferred Stock [Member]
Subsidiary or Equity Method Investee [Line Items]
Preferred stock, shares outstanding				150,000
Proceeds from indebtedness				$ 250,000
Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member]
Subsidiary or Equity Method Investee [Line Items]
Ownership percentage	62.50%
Chief Executive Officer [Member] | Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares issued for common stock	313
Management [Member] | Warrant [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares issued for common stock							14,815
Proceeds from warrants exercised							$ 40,000
Specialty Renal Products, Inc. [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares issued for common stock	62,500
Ownership percentage	62.50%
Specialty Renal Products, Inc. [Member] | Chief Executive Officer [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares issued for common stock						313
Lambda investors LLC [Member] | Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares issued for common stock	25,938
Ownership percentage	36.00%
SRP purchase agreement [Member]
Subsidiary or Equity Method Investee [Line Items]
Sale of stock		600,000
Sale of stock price per share		$ 5.00
Proceeds from sale of stock		$ 3,000,000.0
SRP purchase agreement [Member] | Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member]
Subsidiary or Equity Method Investee [Line Items]
Sale of stock			600,000		100,003
Number of shares issued for common stock	62,500
SRP Purchase Agreement Closing [Member]
Subsidiary or Equity Method Investee [Line Items]
Sale of stock	100,003	100,003
Proceeds from sale of stock	$ 500,015
SRP Purchase Agreement Closing [Member] | Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member]
Subsidiary or Equity Method Investee [Line Items]
Sale of stock	100,003
Loan Agreement [Member] | Specialty Renal Products, Inc. [Member]
Subsidiary or Equity Method Investee [Line Items]
Repayments of debt							1,300,000
Proceeds from Loans									$ 1,000,000.0
Loans payable							$ 1,300,000
Series A Preferred Stock Purchase Agreement [Member] | Specialty Renal Products, Inc. [Member]
Subsidiary or Equity Method Investee [Line Items]
Dividends per share rate				$ 0.40